CD163 by Immunohistochemistry
Also known as: CD163 IHC
Use
The CD163 by Immunohistochemistry test is intended for the identification and characterization of CD163 protein expression. This test is commonly used in clinical oncology for the assessment of macrophage presence in tissue samples, which may correlate with tumor microenvironment conditions and inflammation. It serves as a technical service, providing stained slides for additional pathological evaluation.
Special Instructions
Not provided.
Limitations
The performance characteristics of this test were determined at ARUP Laboratories, and it has not been cleared or approved by the FDA. It is a Laboratory Developed Test (LDT) intended for clinical purposes within CLIA certified laboratories. Results should be interpreted by a qualified pathologist in the context of clinical and other diagnostic findings. Limitations include potential variability in staining and interpretation due to tissue fixation and processing methods.
New York Approved
Methodology
Immunoassay (IHC)
Biomarkers
CD163
Protein
LOINC Codes
- 94736-6 - Tissue block ID Spec
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
2 slides
Container
Tissue transport kit (ARUP supply #47808)
Collection Instructions
Collect tissue or cells, formalin fix, and paraffin embed. If sending precut slides, do not oven bake.
Storage Instructions
Store at room temperature or refrigerated. Ship in a cooled container during summer months.
Causes for Rejection
Depleted specimens; non-representative tissue type.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Indefinitely |
| Refrigerated | Indefinitely |
| Frozen | Indefinitely |
Other tests from different labs that may be relevant